Swedish Regulators Halt Imports from AstraZeneca’s Indian API PlantBy Zachary Brennan - Published 15 December 2015
European imports from AstraZeneca’s now-closed terbutaline sulphate active pharmaceutical ingredient (API) manufacturing facility in Bangalore, India were halted by Sweden’s Medical
No comments:
Post a Comment